您的位置:山东大学 -> 科技期刊社 -> 《山东大学学报(医学版)》

山东大学学报 (医学版) ›› 2021, Vol. 59 ›› Issue (8): 38-43.doi: 10.6040/j.issn.1671-7554.0.2021.0935

• 生殖免疫的基础与临床研究进展专题 • 上一篇    下一篇

免疫抑制剂在风湿病相关复发性流产中的应用

国云飞,舒强   

  1. 山东大学齐鲁医院风湿科, 山东 济南 250012
  • 发布日期:2021-09-16
  • 通讯作者: 舒强. E-mail:shuqiang@sdu.edu.cn
  • 基金资助:
    山东大学临床研究中心急危重症重点专项经费(2021SDUCRCB010)

Role of immunosuppressants in rheumatic disease-associated recurrent spontaneous abortion

GUO Yunfei, SHU Qiang   

  1. Department of Rheumatology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China
  • Published:2021-09-16

摘要: 复发性流产(RSA)的主要病因之一为合并风湿免疫病。近年来,免疫抑制剂在RSA合并风湿免疫病患者的治疗方案中逐渐占据主要地位,其治疗效果也普遍得到认可。由于RSA合并风湿免疫病涉及到多个学科领域,目前对于免疫抑制剂的适应证及用法用量亟待进一步规范。论文结合近年的临床指南和科学研究进展,从RSA定义、风湿病与RSA相关性、免疫抑制剂的使用等方面,对国内外现有文献进行述评,提高读者对于相关疾病及药物的认识,为临床医师在实践中做出合理决策提供参考。

关键词: 免疫抑制剂, 复发性流产, 风湿病, 类风湿关节炎, 系统性红斑狼疮, 结缔组织病

Abstract: One of the main causes of recurrent spontaneous abortion(RSA)is the combination of rheumatologic diseases. In recent years, immunosuppressive agents have gradually taken the main role in the treatment of patients with RSA combined with rheumatologic diseases, and their therapeutic effects are generally recognized. Since RSA combined with rheumatic immune disease involves several disciplines, the indications and dosage of immunosuppressants need to be further standardized. In this paper, we review the existing domestic and international literature in terms of the definition of RSA, the correlation between rheumatic diseases and RSA, and the use of immunosuppressive drugs, in order to improve the readers understanding of related diseases and drugs, and to provide reference for clinicians to make rational decisions in practice.

Key words: Immunosuppressants, Recurrent spontaneous abortion, Rheumatic diseases, Rheumatoid arthritis, Systemic lupus erythematosus, Connective tissue disease

中图分类号: 

  • R593.2
[1] Eudy AM, Siega-Riz AM, Engel SM, et al. Effect of pregnancy on disease flares in patients with systemic lupus erythematosus[J]. Ann Rheum Dis, 2018, 77(6): 855-860.
[2] Sugawara E, Kato M, Fujieda Y, et al. Pregnancy outcomes in women with rheumatic diseases: a real-world observational study in Japan[J]. Lupus, 2019, 28(12): 1407-1416.
[3] 复发性流产合并风湿免疫病免疫抑制剂应用中国专家共识编写组. 复发性流产合并风湿免疫病免疫抑制剂应用中国专家共识[J]. 中华生殖与避孕杂志, 2020, 40(7): 527-534.
[4] 自然流产诊治中国专家共识编写组.自然流产诊治中国专家共识(2020年版)[J]. 中国实用妇科与产科杂志, 2020, 36(11): 1082-1090.
[5] Chen Y, Wu Q, Wei J, et al. Effects of aspirin, vitamin D3, and progesterone on pregnancy outcomes in an autoimmune recurrent spontaneous abortion model[J]. Braz J Med Biol Res, 2021, 54(9): e9570. doi: 10.1590/1414-431X2020e9570.
[6] Ceccarelli F, Pirone C, Perricone C, et al. Pregnancy outcome in systemic lupus erythematosus patients: a monocentric cohort analysis[J]. Rheumatology(Oxford), 2021, 60(4): 1747-1754.
[7] Hiramatsu Y, Isoda K, Kotani T, et al. Pre-pregnancy serum complement C3 level is a predictor of preterm birth for pregnancies with systemic lupus erythematosus[J]. Arthritis Res Ther, 2021, 23(1): 140. doi: 10.1186/s13075-021-02522-x.
[8] Zhang S, Wu Z, Zhang W, et al. Clinical performance of non-criteria antibodies to phospholipids in Chinese patients with antiphospholipid syndrome[J]. Clin Chim Acta, 2019, 495: 205-209. doi: 10.1016/j.cca.2019.04.065.
[9] Nalli C, Lini D, Andreoli L, et al. Low preconception complement levels are associated with adverse pregnancy outcomes in a multicenter study of 260 pregnancies in 197 women with antiphospholipid syndrome or carriers of antiphospholipid antibodies[J]. Biomedicines, 2021, 9(6): 671. doi: 10.3390/biomedicines9060671.
[10] Cohen H, Efthymiou M, Devreese KMJ. Monitoring of anticoagulation in thrombotic antiphospholipid syndrome[J]. J Thromb Haemost, 2021, 19(4): 892-908.
[11] Sammaritano LR, Bermas BL, Chakravarty EE, et al. 2020 American college of rheumatology guideline for the management of reproductive health in rheumatic and musculoskeletal diseases[J]. Arthritis Rheumatol, 2020, 72(4): 529-556.
[12] Bröms G, Kieler H, Ekbom A, et al. Anti-TNF treatment during pregnancy and birth outcomes: a population-based study from Denmark, Finland, and Sweden[J]. Pharmacoepidemiol Drug Saf, 2020, 29(3): 316-327.
[13] Elliott B, Spence AR, Czuzoj-Shulman N, et al. Effect of Sjögrens syndrome on maternal and neonatal outcomes of pregnancy[J]. J Perinat Med, 2019, 47(6): 637-642.
[14] Spinillo A, Beneventi F, Ramoni V, et al. Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy[J]. Annals of the Rheumatic Diseases, 2012, 71(6): 918-923.
[15] Zucchi D, Tani C, Monacci F, et al. Pregnancy and undifferentiated connective tissue disease: outcome and risk of flare in 100 pregnancies[J]. Rheumatology(Oxford), 2020, 59(6): 1335-1339.
[16] de Moreuil C, Alavi Z, Pasquier E. Hydroxychloroquine may be beneficial in preeclampsia and recurrent miscarriage[J]. Br J Clin Pharmacol, 2020, 86(1): 39-49.
[17] Duan J, Ma D, Wen X, et al. Hydroxychloroquine prophylaxis for preeclampsia, hypertension and prematurity in pregnant patients with systemic lupus erythematosus: a meta-analysis[J]. Lupus, 2021, 30(7): 1163-1174.
[18] Yang S, Ni R, Lu Y, et al. A three-arm, multicenter, open-label randomized controlled trial of hydroxychloroquine and low-dose prednisone to treat recurrent pregnancy loss in women with undifferentiated connective tissue diseases: protocol for the Immunosuppressant regimens for LIving FEtuses(ILIFE)trial[J]. Trials, 2020, 21(1): 771. doi: 10.1186/s13063-020-04716-1.
[19] Dong Y, Lu Y, Xia Y, et al. Effect of hydroxychloroquine on antiphospholipid antibodies-inhibited endometrial angiogenesis[J]. J Matern Fetal Neonatal Med, 2021: 1-9. doi: 10.1080/14767058.2021.1943656.
[20] Ou H, Yu Q. Efficacy of aspirin, prednisone, and multivitamin triple therapy in treating unexplained recurrent spontaneous abortion: a cohort study[J]. Int J Gynaecol Obstet, 2020, 148(1): 21-26.
[21] Ince-Askan H, van den Akker ELT, de Rijke YB, et al. Associations between antenatal prednisone exposure and long-term cortisol and cortisone concentrations in children born to women with rheumatoid arthritis: results from a nationwide prospective cohort study[J]. RMD Open, 2019, 5(1): e000852. doi: 10.1136/rmdopen-2018-000852.
[22] De Cock D, Brants L, Soenen I, et al. A systematic review on the effect of DMARDs on fertility in rheumatoid arthritis[J]. Semin Arthritis Rheum, 2020, 50(5): 873-878.
[23] Huang W, Lu W, Li Q, et al. Effects of cyclosporine A on proliferation, invasion and migration of HTR-8/SVneo human extravillous trophoblasts[J]. Biochem Biophys Res Commun, 2020, 533(4): 645-650.
[24] Sharma UR, Rathnakaran AN, Raj BPP, et al. The positive effect of pregnancy in rheumatoid arthritis and the use of medications for the management of rheumatoid arthritis during pregnancy[J]. Inflammopharmacology, 2021, 29(4): 987-1000.
[25] Balbi GGM, Domingues V, Balbi GGM, et al. Use of synthetic and biologic DMARDs during pregnancy[J]. Expert Rev Clin Immunol, 2019, 15(1): 27-39.
[26] Ponticelli C, Moroni G. Fetal toxicity of immunosuppressive drugs in pregnancy[J]. J Clin Med, 2018, 7(12): 552. doi: 10.3390/jcm7120552.
[27] Yang X, Meng T. Is there a role of intravenous immunoglobulin in immunologic recurrent pregnancy loss?[J]. J Immunol Res, 2020, 2020: 6672865. doi: 10.1155/2020/6672865.
[28] Urban ML, Bettiol A, Serena C, et al. Intravenous immunoglobulin for the secondary prevention of stillbirth in obstetric antiphospholipid syndrome: a case series and systematic review of literature[J]. Autoimmun Rev, 2020, 19(9): 102620. doi: 10.1016/j.autrev.2020.102620.
[29] Prieto-Peña D, Calderón-Goercke M, Adán A, et al. Efficacy and safety of certolizumab pegol in pregnant women with uveitis. Recommendations on the management with immunosuppressive and biologic therapies in uveitis during pregnancy[J]. Clin Exp Rheumatol, 2021, 39(1): 105-114.
[30] Perrotta K, Kiernan E, Bandoli G, et al. Pregnancy outcomes following maternal treatment with rituximab prior to or during pregnancy: a case series[J]. Rheumatol Adv Pract, 2021, 5(1): rkaa074. doi: 10.1093/rap/rkaa074.
[31] Saito J, Yakuwa N, Kaneko K, et al. Tocilizumab during pregnancy and lactation: drug levels in maternal serum, cord blood, breast milk and infant serum[J]. Rheumatology(Oxford), 2019, 58(8): 1505-1507.
[32] Fanouriakis A, Kostopoulou M, Alunno A, et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus[J]. Ann Rheum Dis, 2019, 78(6): 736-745.
[33] Akhlaghi M, Kianersi F, Radmehr H, et al. Evaluation of optical coherence tomography angiography parameters in patients treated with Hydroxychloroquine[J]. BMC Ophthalmol, 2021, 21(1): 209. doi: 10.1186/s12886-021-01977-5.
[1] 成晅,杨帆,潘正论. 系统性红斑狼疮、抗磷脂抗体综合征伴颅内静脉窦血栓形成1例并文献复习[J]. 山东大学学报 (医学版), 2022, 60(6): 70-74.
[2] 杨岫岩,张建瑜. 从风湿免疫角度谈生殖免疫的一些思路[J]. 山东大学学报 (医学版), 2021, 59(8): 20-23.
[3] 赵冰清,高选,李江夏. 基于辅助生殖人群的复发性流产夫妇染色体核型回顾性分析[J]. 山东大学学报 (医学版), 2021, 59(7): 26-31.
[4] 王百惠,宋艳君,张帅庆,左秀丽,王青,张爱军,李如源. 以腹泻为首发症状的淀粉样变3例及文献复习[J]. 山东大学学报 (医学版), 2020, 58(5): 93-97.
[5] 冯洒然,刘倩,王焱,李红,毕可红,朱传升. 系统性红斑狼疮伴发肝脾γδT细胞淋巴瘤1例并文献复习[J]. 山东大学学报 (医学版), 2018, 56(6): 87-90.
[6] 张好. 系统性红斑狼疮合并狼疮脑病、重症自身免疫性胰腺炎1例[J]. 山东大学学报 (医学版), 2018, 56(2): 93-94.
[7] 曲晓霞. 有汗性外胚叶发育不良合并系统性红斑狼疮1例[J]. 山东大学学报 (医学版), 2018, 56(2): 95-96.
[8] 杜金阁,陈慧,杨孝荣,吕明. STAT4 rs7574865位点单核苷酸多态性与系统性红斑狼疮易感性Meta分析[J]. 山东大学学报(医学版), 2017, 55(5): 95-102.
[9] 徐大霞,侯楠,李晓峰,王闯,孔猛,焦广俊,陈允震. 糖皮质激素性骨质疏松症骨代谢与糖皮质激素用药时间的相关性[J]. 山东大学学报(医学版), 2017, 55(5): 103-107.
[10] 麻贞贞,孙红胜,杨清锐. 脂联素、内脂素、抵抗素在系统性红斑狼疮患者血清中的变化及临床意义[J]. 山东大学学报(医学版), 2017, 55(4): 86-90.
[11] 李健,徐冰,闫新峰,徐万菊,常晓天. 筛选TXNDC5与胰岛素相关信号通路关键基因的探讨[J]. 山东大学学报(医学版), 2017, 55(3): 88-93.
[12] 赵琰,郑亚冰,闫新峰,张虎,常晓天. 筛选类风湿关节炎中糖代谢关键基因的探讨[J]. 山东大学学报(医学版), 2016, 54(3): 30-35.
[13] 姜慧钰, 王林, 潘继红. siRNA沉默PCSK6基因对胶原诱导性关节炎的影响[J]. 山东大学学报(医学版), 2015, 53(12): 20-26.
[14] 潘娟, 胡慧. 系统性红斑狼疮合并2型糖尿病1例个案管理报道[J]. 山东大学学报(医学版), 2014, 52(S2): 64-65.
[15] 郑加田,朱凯,孙红胜,付敏,潘正论. IL-18和MCP-1基因多态性与类风湿关节炎易感性关系的Meta分析[J]. 山东大学学报(医学版), 2014, 52(6): 98-104.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
[1] 姜保东,马祥兴,王青,王茜,冯晓源,李克,于富华 . 脑CT静脉造影扫描时相及重建层厚的选择[J]. 山东大学学报(医学版), 2008, 46(11): 1084 -1086 .
[2] 史爽,李娟,米琦,王允山,杜鲁涛,王传新. 胃癌miRNAs预后风险评分模型的构建与应用[J]. 山东大学学报 (医学版), 2020, 1(7): 47 -52 .
[3] 黄飞,王怀经,邢毅,高薇,李永刚,邢子英,李振中. NGF和GM1联合应用对坐骨神经损伤大鼠初级传入神经元的保护作用[J]. 山东大学学报(医学版), 2006, 44(4): 332 -335 .
[4] 吕龙飞,李林,李树海,亓磊,鲁铭,程传乐,田辉. 腔镜下细针导管空肠造瘘在微创McKeown食管癌切除术中的应用[J]. 山东大学学报 (医学版), 2020, 1(7): 77 -81 .
[5] 邵海港, 王璇, 王青. 山东地区人下颌第一前磨牙根管系统解剖研究[J]. 山东大学学报(医学版), 2014, 52(9): 85 -89 .
[6] 唐芳1,2 ,张颖倩3 ,王志强4 ,康殿民4 ,王洁贞1 ,薛付忠1 . 自然疫源性疾病疫源地空间结构的二维
最小生成树模型及其应用
[J]. 山东大学学报(医学版), 2009, 47(01): 106 -110 .
[7] 朱晓丽1,郭淑玲1,苏磊1,冯玉新2,袁方曙1. 蠕形螨全蛋白提取及相对分子量鉴定[J]. 山东大学学报(医学版), 2014, 52(5): 58 -62 .
[8] 李洧,李道卫,叶茜,高顺翠,姜淑娟. 经支气管镜针吸活检在纵隔疾病诊断中的价值[J]. 山东大学学报(医学版), 2008, 46(11): 1063 -1065 .
[9] 刘海春 张剑锋 陈允震. 骨质疏松大鼠股骨生物力学特性与骨胶原质量变化的相关研究[J]. 山东大学学报(医学版), 2009, 47(5): 42 -45 .
[10] 冯复利1,魏树珍2,张永欢3,李莉1,陈融1,李瑞峰1. 胰岛素抵抗大鼠高死亡率与Klotho表达关系的研究[J]. 山东大学学报(医学版), 2010, 48(6): 5 -8 .